Description: Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to approximately 30 countries. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.
Home Page: www.balpharma.com
Lakshmi Narayan Complex
Bengaluru,
560052
India
Phone:
91 80 4137 9500
Officers
| Name | Title |
|---|---|
| Mr. Shailesh Dheerajmal Siroya | MD & Executive Director |
| Mr. Daddanala Venkat Bharath Bhushan | Chief Financial Officer |
| Mr. Abdul Basith | Company Secretary & Compliance Officer |
| Mr. Himesh Virupakshaya | Whole Time Director |
| Mr. Ravindra Kumar Kothari | Deputy General Manager of Internal Audit, Legal and Compliances |
| Mr. D. L. Bhat | Assistant Vice President of Sales & Marketing |
| Ms. Archana Dubey Mitra | Vice President of International Marketing & HR |
| Mr. Kotian Chittananda Damodar | Whole Time Director |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 24.6548 |
| Price-to-Book MRQ: | 2.8929 |
| Price-to-Sales TTM: | 0.5799 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 868 |